期刊
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN
卷 4, 期 12, 页码 -出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/GOX.0000000000001155
关键词
-
类别
资金
- Allergan plc
Background: KYBELLA, ATX-101, is an injectable form of sodium deoxycholic acid. It is currently the only Food and Drug Administration-approved injectable drug for the reduction of submental fat. Objectives: A literature review and discussion of the treatment of submental fat. Results: KYBELLA is a well-tolerated alternative for the treatment of submental fat. Conclusions: KYBELLA is a safe and efficacious, first in class, injectable drug for the reduction of submental fat.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据